Argenx SE

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

58.96%

Market Cap

46.60 Bil.

P/E Ratio

38.38

Dividend Yield

0.00 %

Earnings per Share

18.68 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORM
LAST PRICE781 G0 Units
PRICE DETERMINATION TIME06/25/2026 / 06:02:13 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW781744.8
PREV. DAY'S PRICE753 (06/24)
CHANGE DAY BEFORE
+28.00
3.72 %
52 WEEK HIGH / LOW820.2 (06/23)454.2 (07/09)
More Price Information

Key Figures (in EUR)

2027e2026e202520242023
EARNINGS PER SHARE29.9322.4318.6812.87-4.77
DIVIDENDS PER SHARE0.000.000.000.000.00
DIVIDEND YIELD IN %--0.00 %0.00 %0.00 %
DIVIDEND GROWTH IN %-----
PRICE - EARNINGS RATIO25.0133.3838.3846.63-
PRICE - BOOK RATIO--7.116.875.48
PRICE - SALES RATIO--12.8619.3117.31
PRICE - CASH FLOW RATIO--63.001,463.61-
Further Key Figures

Master Data

WKN
A11602
ISIN
NL0010832176
SYMBOL
1AE
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
ARGENX SE EO -,10
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Euro
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
61.88 Mil.
MARKET CAPITALISATION
46.60 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-3.14 %
8.66 %
28.85 %
5.29 %
58.96 %
107.21 %
188.95 %
4.99 %
HIGH820.20820.20820.20820.20820.20820.20820.20820.20
LOW737.40675.00583.20564.80454.20290.80226.50564.80
Dividend
per share
ARGENX SE EO -,10 does not deliver dividend information

Company profile

argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.